

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.31661315 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.95186674 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.27559218 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 4.99265213 |
| 5 | glutamate secretion (GO:0014047) | 4.81500555 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.61265829 |
| 7 | layer formation in cerebral cortex (GO:0021819) | 4.46872509 |
| 8 | locomotory exploration behavior (GO:0035641) | 4.43952199 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.33879190 |
| 10 | protein retention in ER lumen (GO:0006621) | 4.22955891 |
| 11 | proline transport (GO:0015824) | 4.11535987 |
| 12 | regulation of synaptic vesicle transport (GO:1902803) | 4.05030015 |
| 13 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.01843379 |
| 14 | negative regulation of microtubule polymerization (GO:0031115) | 3.94319502 |
| 15 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.85967915 |
| 16 | neurotransmitter secretion (GO:0007269) | 3.83565345 |
| 17 | vocalization behavior (GO:0071625) | 3.76379807 |
| 18 | cell migration in hindbrain (GO:0021535) | 3.72550880 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.64806976 |
| 20 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.63757376 |
| 21 | exploration behavior (GO:0035640) | 3.63025473 |
| 22 | protein localization to synapse (GO:0035418) | 3.59799179 |
| 23 | sodium ion export (GO:0071436) | 3.48482257 |
| 24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.47484299 |
| 25 | neuron cell-cell adhesion (GO:0007158) | 3.45433955 |
| 26 | activation of protein kinase A activity (GO:0034199) | 3.40685500 |
| 27 | innervation (GO:0060384) | 3.38310739 |
| 28 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.33641827 |
| 29 | L-serine transport (GO:0015825) | 3.33227161 |
| 30 | neuronal action potential propagation (GO:0019227) | 3.32901975 |
| 31 | response to pheromone (GO:0019236) | 3.31023969 |
| 32 | dendritic spine morphogenesis (GO:0060997) | 3.25391836 |
| 33 | cellular potassium ion homeostasis (GO:0030007) | 3.21986875 |
| 34 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.21754242 |
| 35 | regulation of synapse structural plasticity (GO:0051823) | 3.19580570 |
| 36 | type B pancreatic cell proliferation (GO:0044342) | 3.17311527 |
| 37 | positive regulation of synapse maturation (GO:0090129) | 3.16551718 |
| 38 | regulation of early endosome to late endosome transport (GO:2000641) | 3.15553839 |
| 39 | neurotransmitter transport (GO:0006836) | 3.14108708 |
| 40 | protein localization to endosome (GO:0036010) | 3.13344345 |
| 41 | protein heterotrimerization (GO:0070208) | 3.10887027 |
| 42 | barbed-end actin filament capping (GO:0051016) | 3.09973446 |
| 43 | organelle transport along microtubule (GO:0072384) | 3.09025765 |
| 44 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.09001636 |
| 45 | detection of temperature stimulus (GO:0016048) | 3.07994690 |
| 46 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.05518390 |
| 47 | establishment of mitochondrion localization (GO:0051654) | 3.04078720 |
| 48 | axon extension (GO:0048675) | 3.01023241 |
| 49 | kidney mesenchyme development (GO:0072074) | 2.99600541 |
| 50 | neuromuscular process controlling balance (GO:0050885) | 2.99338239 |
| 51 | neuron recognition (GO:0008038) | 2.96743449 |
| 52 | vesicle transport along microtubule (GO:0047496) | 2.96558899 |
| 53 | neuromuscular process controlling posture (GO:0050884) | 2.96221906 |
| 54 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.95659962 |
| 55 | mitochondrion transport along microtubule (GO:0047497) | 2.95659962 |
| 56 | cerebellar Purkinje cell layer development (GO:0021680) | 2.93889515 |
| 57 | serine transport (GO:0032329) | 2.93768004 |
| 58 | extracellular fibril organization (GO:0043206) | 2.93561673 |
| 59 | metanephric mesenchyme development (GO:0072075) | 2.91330089 |
| 60 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.89922768 |
| 61 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.89142785 |
| 62 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.88174167 |
| 63 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.87816435 |
| 64 | synaptic transmission, glutamatergic (GO:0035249) | 2.87704877 |
| 65 | skin morphogenesis (GO:0043589) | 2.86676422 |
| 66 | cell communication by electrical coupling (GO:0010644) | 2.85082663 |
| 67 | regulation of vesicle fusion (GO:0031338) | 2.84636692 |
| 68 | regulation of neurotransmitter levels (GO:0001505) | 2.82742494 |
| 69 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.82333709 |
| 70 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.80324401 |
| 71 | positive regulation of mitochondrial fission (GO:0090141) | 2.79907913 |
| 72 | gamma-aminobutyric acid transport (GO:0015812) | 2.78068231 |
| 73 | membrane repolarization (GO:0086009) | 2.77551782 |
| 74 | vesicle coating (GO:0006901) | 2.77252678 |
| 75 | neuron projection extension (GO:1990138) | 2.76980414 |
| 76 | neuron-neuron synaptic transmission (GO:0007270) | 2.76598650 |
| 77 | COPI coating of Golgi vesicle (GO:0048205) | 2.76429158 |
| 78 | Golgi transport vesicle coating (GO:0048200) | 2.76429158 |
| 79 | mating behavior (GO:0007617) | 2.75445016 |
| 80 | axon cargo transport (GO:0008088) | 2.75306688 |
| 81 | glycine transport (GO:0015816) | 2.73257277 |
| 82 | peptidyl-proline hydroxylation (GO:0019511) | 2.73042624 |
| 83 | protein maturation by protein folding (GO:0022417) | 2.73027725 |
| 84 | regulation of synaptic plasticity (GO:0048167) | 2.71235741 |
| 85 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.69625967 |
| 86 | actin filament depolymerization (GO:0030042) | 2.67895762 |
| 87 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.67295852 |
| 88 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.65993001 |
| 89 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.65993001 |
| 90 | dendritic spine organization (GO:0097061) | 2.65959475 |
| 91 | axonal fasciculation (GO:0007413) | 2.65244007 |
| 92 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.64862943 |
| 93 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.64623006 |
| 94 | dendrite morphogenesis (GO:0048813) | 2.64513912 |
| 95 | synaptic vesicle endocytosis (GO:0048488) | 2.63841863 |
| 96 | stress fiber assembly (GO:0043149) | 2.63644471 |
| 97 | positive regulation of membrane potential (GO:0045838) | 2.60592551 |
| 98 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.59709188 |
| 99 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.59136288 |
| 100 | glutamate receptor signaling pathway (GO:0007215) | 2.58665707 |
| 101 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.57783126 |
| 102 | positive regulation of axon extension (GO:0045773) | 2.56428987 |
| 103 | establishment of vesicle localization (GO:0051650) | 2.54968946 |
| 104 | synapse organization (GO:0050808) | 2.54700347 |
| 105 | membrane repolarization during action potential (GO:0086011) | 2.54039317 |
| 106 | positive regulation of exocytosis (GO:0045921) | 2.52631775 |
| 107 | long-term synaptic potentiation (GO:0060291) | 2.51529567 |
| 108 | neuromuscular process (GO:0050905) | 2.51076894 |
| 109 | fibril organization (GO:0097435) | 2.48948284 |
| 110 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.48256036 |
| 111 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.47397983 |
| 112 | regulation of neurotransmitter secretion (GO:0046928) | 2.46850599 |
| 113 | behavioral fear response (GO:0001662) | 2.46173739 |
| 114 | behavioral defense response (GO:0002209) | 2.46173739 |
| 115 | cerebellum development (GO:0021549) | 2.46044094 |
| 116 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.45910833 |
| 117 | regulation of autophagic vacuole assembly (GO:2000785) | 2.45694295 |
| 118 | basement membrane organization (GO:0071711) | 2.45562832 |
| 119 | receptor recycling (GO:0001881) | 2.45106914 |
| 120 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.43785119 |
| 121 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.43674160 |
| 122 | cerebellar granule cell differentiation (GO:0021707) | 2.43122550 |
| 123 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.42885867 |
| 124 | synaptic vesicle transport (GO:0048489) | 2.42797612 |
| 125 | establishment of synaptic vesicle localization (GO:0097480) | 2.42797612 |
| 126 | regulation of protein targeting to membrane (GO:0090313) | 2.37591733 |
| 127 | protein hydroxylation (GO:0018126) | 2.37518747 |
| 128 | amino acid import (GO:0043090) | 2.34227622 |
| 129 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.33924395 |
| 130 | cell adhesion mediated by integrin (GO:0033627) | 2.29258118 |
| 131 | potassium ion homeostasis (GO:0055075) | 2.29161170 |
| 132 | cellular copper ion homeostasis (GO:0006878) | 2.28456613 |
| 133 | virion attachment to host cell (GO:0019062) | 2.28229127 |
| 134 | adhesion of symbiont to host cell (GO:0044650) | 2.28229127 |
| 135 | protein insertion into membrane (GO:0051205) | 2.27073564 |
| 136 | 4-hydroxyproline metabolic process (GO:0019471) | 2.26526207 |
| 137 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.25644956 |
| 138 | neuronal ion channel clustering (GO:0045161) | 2.25381763 |
| 139 | endoplasmic reticulum organization (GO:0007029) | 2.25070237 |
| 140 | growth hormone secretion (GO:0030252) | 2.24875686 |
| 141 | positive regulation of vesicle fusion (GO:0031340) | 2.20963537 |
| 142 | positive regulation of protein targeting to membrane (GO:0090314) | 2.19232092 |
| 143 | adhesion of symbiont to host (GO:0044406) | 2.18891240 |
| 144 | developmental cell growth (GO:0048588) | 2.18870761 |
| 145 | nuclear envelope reassembly (GO:0031468) | 2.18341204 |
| 146 | mitotic nuclear envelope reassembly (GO:0007084) | 2.18341204 |
| 147 | protein targeting to plasma membrane (GO:0072661) | 2.18160847 |
| 148 | postsynaptic membrane organization (GO:0001941) | 2.18153584 |
| 149 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.15860643 |
| 150 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.14807382 |
| 151 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.13588326 |
| 152 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.13255303 |
| 153 | membrane budding (GO:0006900) | 2.12771378 |
| 154 | transferrin transport (GO:0033572) | 2.12647393 |
| 155 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.11893776 |
| 156 | negative regulation of catenin import into nucleus (GO:0035414) | 2.10894471 |
| 157 | axon extension involved in axon guidance (GO:0048846) | 2.10679491 |
| 158 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.10679491 |
| 159 | extracellular matrix assembly (GO:0085029) | 2.09207509 |
| 160 | negative regulation of cell size (GO:0045792) | 2.08470523 |
| 161 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.07648598 |
| 162 | detection of calcium ion (GO:0005513) | 2.07452765 |
| 163 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.05763423 |
| 164 | substantia nigra development (GO:0021762) | 2.04186811 |
| 165 | collagen fibril organization (GO:0030199) | 2.03176584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.64240919 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.02754887 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.93547067 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.09992926 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.07133032 |
| 6 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.89955348 |
| 7 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.85534834 |
| 8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.77912428 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.66617791 |
| 10 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.57178300 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.55367466 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.52267358 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.47441686 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.47190244 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.47190244 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.46176228 |
| 17 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.46004060 |
| 18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.40674222 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.37141414 |
| 20 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.34368968 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.31816096 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.29809999 |
| 23 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.22110319 |
| 24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.21811538 |
| 25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.21337806 |
| 26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.15817333 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.12908059 |
| 28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.11421708 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.04077052 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.99673108 |
| 31 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.98688295 |
| 32 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.97037938 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.94439599 |
| 34 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.93038491 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.90050614 |
| 36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.88565724 |
| 37 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.84559858 |
| 38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.82184650 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.80260325 |
| 40 | KDM2B_26808549_Chip-Seq_K562_Human | 1.77573459 |
| 41 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.76003615 |
| 42 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73747113 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.73653802 |
| 44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.70464024 |
| 45 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.70096409 |
| 46 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.63962825 |
| 47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.63449176 |
| 48 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.61736717 |
| 49 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.58695942 |
| 50 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.57870016 |
| 51 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.56051974 |
| 52 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.53062322 |
| 53 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.52672830 |
| 54 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.51519721 |
| 55 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50536449 |
| 56 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.47907426 |
| 57 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.45628351 |
| 58 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.44156721 |
| 59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.43384715 |
| 60 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.39659759 |
| 61 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.38908878 |
| 62 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.38033964 |
| 63 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37391851 |
| 64 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.35154996 |
| 65 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.34667144 |
| 66 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.34056248 |
| 67 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.33875169 |
| 68 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.31749631 |
| 69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29619913 |
| 70 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.28817616 |
| 71 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28771320 |
| 72 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.27946340 |
| 73 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.25192796 |
| 74 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.25015725 |
| 75 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.23466593 |
| 76 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23330683 |
| 77 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22862989 |
| 78 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.21970562 |
| 79 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.21970562 |
| 80 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.21970562 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.21287370 |
| 82 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20642453 |
| 83 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.19293996 |
| 84 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.19173258 |
| 85 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.19089308 |
| 86 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.18513279 |
| 87 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.17447770 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16457894 |
| 89 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.16234875 |
| 90 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.15326007 |
| 91 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14884898 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14284085 |
| 93 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.14253681 |
| 94 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.13226656 |
| 95 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10653282 |
| 96 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.10428974 |
| 97 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.09945958 |
| 98 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08773687 |
| 99 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06678149 |
| 100 | AR_19668381_ChIP-Seq_PC3_Human | 1.06587284 |
| 101 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.05028995 |
| 102 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.05028995 |
| 103 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.03897942 |
| 104 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.03884382 |
| 105 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.03469717 |
| 106 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.02987642 |
| 107 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.00798046 |
| 108 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.00267449 |
| 109 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.00184387 |
| 110 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99065067 |
| 111 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98926219 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98918250 |
| 113 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98833018 |
| 114 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.98279481 |
| 115 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.97989586 |
| 116 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.97615704 |
| 117 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97598595 |
| 118 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96019781 |
| 119 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.95663521 |
| 120 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95130799 |
| 121 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93385538 |
| 122 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.93154632 |
| 123 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92894640 |
| 124 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92236332 |
| 125 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91569327 |
| 126 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.90906532 |
| 127 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.90615389 |
| 128 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.90547078 |
| 129 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90461260 |
| 130 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90412455 |
| 131 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89803752 |
| 132 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.89706767 |
| 133 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89048326 |
| 134 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.87904972 |
| 135 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87663166 |
| 136 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86129666 |
| 137 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.85798353 |
| 138 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85584200 |
| 139 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.84507705 |
| 140 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.82572207 |
| 141 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.82187725 |
| 142 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.79530953 |
| 143 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.78065026 |
| 144 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.77964395 |
| 145 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.77065606 |
| 146 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.77052711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.09651797 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 4.73894208 |
| 3 | MP0004270_analgesia | 3.79860608 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.25684205 |
| 5 | MP0003880_abnormal_central_pattern | 3.11797577 |
| 6 | MP0004858_abnormal_nervous_system | 2.92565931 |
| 7 | MP0002063_abnormal_learning/memory/cond | 2.63706989 |
| 8 | MP0002064_seizures | 2.44527157 |
| 9 | MP0002734_abnormal_mechanical_nocicepti | 2.30353677 |
| 10 | MP0009745_abnormal_behavioral_response | 2.27311629 |
| 11 | MP0004272_abnormal_basement_membrane | 2.26769196 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.25283263 |
| 13 | MP0003329_amyloid_beta_deposits | 2.21489136 |
| 14 | MP0003283_abnormal_digestive_organ | 2.20589996 |
| 15 | MP0003279_aneurysm | 2.20533472 |
| 16 | MP0003122_maternal_imprinting | 2.20505133 |
| 17 | MP0002733_abnormal_thermal_nociception | 2.19643276 |
| 18 | MP0002909_abnormal_adrenal_gland | 2.18723317 |
| 19 | MP0002653_abnormal_ependyma_morphology | 2.15790506 |
| 20 | MP0005275_abnormal_skin_tensile | 2.15590456 |
| 21 | MP0009046_muscle_twitch | 2.14049268 |
| 22 | MP0002572_abnormal_emotion/affect_behav | 2.09222727 |
| 23 | MP0001958_emphysema | 2.04462881 |
| 24 | MP0005257_abnormal_intraocular_pressure | 2.04289608 |
| 25 | MP0002272_abnormal_nervous_system | 1.99276822 |
| 26 | MP0005503_abnormal_tendon_morphology | 1.97090618 |
| 27 | MP0005423_abnormal_somatic_nervous | 1.95850749 |
| 28 | MP0002735_abnormal_chemical_nociception | 1.89672160 |
| 29 | MP0001542_abnormal_bone_strength | 1.87964584 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.86863472 |
| 31 | MP0005499_abnormal_olfactory_system | 1.81556422 |
| 32 | MP0005394_taste/olfaction_phenotype | 1.81556422 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.80371375 |
| 34 | MP0010368_abnormal_lymphatic_system | 1.78917717 |
| 35 | MP0001970_abnormal_pain_threshold | 1.78643351 |
| 36 | MP0002736_abnormal_nociception_after | 1.75870701 |
| 37 | MP0002184_abnormal_innervation | 1.75700520 |
| 38 | MP0000955_abnormal_spinal_cord | 1.72880114 |
| 39 | MP0006072_abnormal_retinal_apoptosis | 1.71376113 |
| 40 | MP0008260_abnormal_autophagy | 1.66753503 |
| 41 | MP0000778_abnormal_nervous_system | 1.65300866 |
| 42 | MP0006276_abnormal_autonomic_nervous | 1.64585179 |
| 43 | MP0008961_abnormal_basal_metabolism | 1.58078585 |
| 44 | MP0000749_muscle_degeneration | 1.54665747 |
| 45 | MP0004885_abnormal_endolymph | 1.52691751 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.51215533 |
| 47 | MP0002067_abnormal_sensory_capabilities | 1.48622735 |
| 48 | MP0001440_abnormal_grooming_behavior | 1.48185179 |
| 49 | MP0000750_abnormal_muscle_regeneration | 1.48112789 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.47973017 |
| 51 | MP0004233_abnormal_muscle_weight | 1.47966890 |
| 52 | MP0010234_abnormal_vibrissa_follicle | 1.46989454 |
| 53 | MP0001486_abnormal_startle_reflex | 1.45005394 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.43895029 |
| 55 | MP0002295_abnormal_pulmonary_circulatio | 1.40659872 |
| 56 | MP0003705_abnormal_hypodermis_morpholog | 1.40392069 |
| 57 | MP0001348_abnormal_lacrimal_gland | 1.40349541 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.39715130 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.39320635 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 1.36927368 |
| 61 | MP0002557_abnormal_social/conspecific_i | 1.30378999 |
| 62 | MP0002896_abnormal_bone_mineralization | 1.27811515 |
| 63 | MP0004145_abnormal_muscle_electrophysio | 1.26985304 |
| 64 | MP0002066_abnormal_motor_capabilities/c | 1.25254677 |
| 65 | MP0008569_lethality_at_weaning | 1.25109884 |
| 66 | MP0009384_cardiac_valve_regurgitation | 1.21563115 |
| 67 | MP0008789_abnormal_olfactory_epithelium | 1.19910297 |
| 68 | MP0005508_abnormal_skeleton_morphology | 1.19794363 |
| 69 | MP0000733_abnormal_muscle_development | 1.17973298 |
| 70 | MP0003879_abnormal_hair_cell | 1.15481166 |
| 71 | MP0002229_neurodegeneration | 1.13546384 |
| 72 | MP0005623_abnormal_meninges_morphology | 1.13300807 |
| 73 | MP0009840_abnormal_foam_cell | 1.13073859 |
| 74 | MP0005386_behavior/neurological_phenoty | 1.12967740 |
| 75 | MP0004924_abnormal_behavior | 1.12967740 |
| 76 | MP0003634_abnormal_glial_cell | 1.12542847 |
| 77 | MP0002152_abnormal_brain_morphology | 1.11471144 |
| 78 | MP0003091_abnormal_cell_migration | 1.11393532 |
| 79 | MP0010386_abnormal_urinary_bladder | 1.10718642 |
| 80 | MP0004043_abnormal_pH_regulation | 1.10115268 |
| 81 | MP0001984_abnormal_olfaction | 1.08757119 |
| 82 | MP0003123_paternal_imprinting | 1.08690783 |
| 83 | MP0003385_abnormal_body_wall | 1.07706346 |
| 84 | MP0000751_myopathy | 1.06557990 |
| 85 | MP0000920_abnormal_myelination | 1.03384810 |
| 86 | MP0002877_abnormal_melanocyte_morpholog | 1.02569718 |
| 87 | MP0001502_abnormal_circadian_rhythm | 1.02100546 |
| 88 | MP0000467_abnormal_esophagus_morphology | 1.01867146 |
| 89 | MP0005409_darkened_coat_color | 1.01812457 |
| 90 | MP0005551_abnormal_eye_electrophysiolog | 1.01507029 |
| 91 | MP0004142_abnormal_muscle_tone | 0.99782834 |
| 92 | MP0002752_abnormal_somatic_nervous | 0.98670322 |
| 93 | MP0004087_abnormal_muscle_fiber | 0.98410479 |
| 94 | MP0000767_abnormal_smooth_muscle | 0.98005066 |
| 95 | MP0000762_abnormal_tongue_morphology | 0.97385396 |
| 96 | MP0003633_abnormal_nervous_system | 0.97049541 |
| 97 | MP0005187_abnormal_penis_morphology | 0.92451505 |
| 98 | MP0003119_abnormal_digestive_system | 0.92278998 |
| 99 | MP0001270_distended_abdomen | 0.90523374 |
| 100 | MP0005253_abnormal_eye_physiology | 0.89836526 |
| 101 | MP0002751_abnormal_autonomic_nervous | 0.89688283 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.89381965 |
| 103 | MP0002332_abnormal_exercise_endurance | 0.89063206 |
| 104 | MP0003075_altered_response_to | 0.88840426 |
| 105 | MP0003890_abnormal_embryonic-extraembry | 0.88327025 |
| 106 | MP0003861_abnormal_nervous_system | 0.87627690 |
| 107 | MP0003221_abnormal_cardiomyocyte_apopto | 0.87580065 |
| 108 | MP0000747_muscle_weakness | 0.87294333 |
| 109 | MP0003950_abnormal_plasma_membrane | 0.86601542 |
| 110 | MP0008874_decreased_physiological_sensi | 0.85955568 |
| 111 | MP0002234_abnormal_pharynx_morphology | 0.85723492 |
| 112 | MP0001905_abnormal_dopamine_level | 0.85661435 |
| 113 | MP0003121_genomic_imprinting | 0.85629060 |
| 114 | MP0000534_abnormal_ureter_morphology | 0.85398654 |
| 115 | MP0002060_abnormal_skin_morphology | 0.84489380 |
| 116 | MP0005165_increased_susceptibility_to | 0.83820394 |
| 117 | MP0002837_dystrophic_cardiac_calcinosis | 0.82658713 |
| 118 | MP0010030_abnormal_orbit_morphology | 0.82483840 |
| 119 | MP0000604_amyloidosis | 0.82013372 |
| 120 | MP0003787_abnormal_imprinting | 0.81034021 |
| 121 | MP0002069_abnormal_eating/drinking_beha | 0.80723901 |
| 122 | MP0002822_catalepsy | 0.80292828 |
| 123 | MP0003631_nervous_system_phenotype | 0.80107262 |
| 124 | MP0004510_myositis | 0.79920076 |
| 125 | MP0001529_abnormal_vocalization | 0.79853847 |
| 126 | MP0002106_abnormal_muscle_physiology | 0.79316149 |
| 127 | MP0003172_abnormal_lysosome_physiology | 0.78509747 |
| 128 | MP0002269_muscular_atrophy | 0.77436127 |
| 129 | MP0004085_abnormal_heartbeat | 0.77258999 |
| 130 | MP0005330_cardiomyopathy | 0.76892174 |
| 131 | MP0002090_abnormal_vision | 0.76090100 |
| 132 | MP0001879_abnormal_lymphatic_vessel | 0.75635540 |
| 133 | MP0001188_hyperpigmentation | 0.75023535 |
| 134 | MP0001849_ear_inflammation | 0.74068810 |
| 135 | MP0000631_abnormal_neuroendocrine_gland | 0.73966741 |
| 136 | MP0005248_abnormal_Harderian_gland | 0.73096446 |
| 137 | MP0003115_abnormal_respiratory_system | 0.72314033 |
| 138 | MP0003632_abnormal_nervous_system | 0.72233483 |
| 139 | MP0005369_muscle_phenotype | 0.71844411 |
| 140 | MP0006054_spinal_hemorrhage | 0.69672793 |
| 141 | MP0005645_abnormal_hypothalamus_physiol | 0.67384324 |
| 142 | MP0000003_abnormal_adipose_tissue | 0.66176625 |
| 143 | MP0005195_abnormal_posterior_eye | 0.66171904 |
| 144 | MP0001944_abnormal_pancreas_morphology | 0.65091110 |
| 145 | MP0003942_abnormal_urinary_system | 0.64758123 |
| 146 | MP0000639_abnormal_adrenal_gland | 0.60019871 |
| 147 | MP0000759_abnormal_skeletal_muscle | 0.58514602 |
| 148 | MP0006035_abnormal_mitochondrial_morpho | 0.58012420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.14270803 |
| 2 | Myokymia (HP:0002411) | 5.04315403 |
| 3 | Visual hallucinations (HP:0002367) | 4.79971552 |
| 4 | Protrusio acetabuli (HP:0003179) | 4.70426840 |
| 5 | Focal seizures (HP:0007359) | 3.91790572 |
| 6 | Focal motor seizures (HP:0011153) | 3.80312668 |
| 7 | Abnormality of the lower motor neuron (HP:0002366) | 3.79302596 |
| 8 | Atonic seizures (HP:0010819) | 3.64132642 |
| 9 | Type 1 muscle fiber predominance (HP:0003803) | 3.37383788 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 3.35792376 |
| 11 | Vertebral compression fractures (HP:0002953) | 3.31211434 |
| 12 | Epileptic encephalopathy (HP:0200134) | 3.23483850 |
| 13 | Absence seizures (HP:0002121) | 3.23136613 |
| 14 | Dialeptic seizures (HP:0011146) | 3.09680337 |
| 15 | Ankle contracture (HP:0006466) | 3.05212639 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 3.04747321 |
| 17 | Action tremor (HP:0002345) | 3.01886193 |
| 18 | Spinal rigidity (HP:0003306) | 3.00414811 |
| 19 | Insidious onset (HP:0003587) | 2.98461194 |
| 20 | Termporal pattern (HP:0011008) | 2.98461194 |
| 21 | Vascular tortuosity (HP:0004948) | 2.97159832 |
| 22 | Abnormality of dentin (HP:0010299) | 2.82587275 |
| 23 | Ankle clonus (HP:0011448) | 2.81214051 |
| 24 | Depression (HP:0000716) | 2.81213138 |
| 25 | Amyotrophic lateral sclerosis (HP:0007354) | 2.78761895 |
| 26 | Increased variability in muscle fiber diameter (HP:0003557) | 2.78225843 |
| 27 | Cerebral inclusion bodies (HP:0100314) | 2.70214082 |
| 28 | Atrophic scars (HP:0001075) | 2.69083186 |
| 29 | Amblyopia (HP:0000646) | 2.67409271 |
| 30 | Arterial tortuosity (HP:0005116) | 2.64794525 |
| 31 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.63577354 |
| 32 | Pheochromocytoma (HP:0002666) | 2.58381164 |
| 33 | Abnormality of the corticospinal tract (HP:0002492) | 2.56408908 |
| 34 | Exercise-induced myalgia (HP:0003738) | 2.56120636 |
| 35 | Follicular hyperkeratosis (HP:0007502) | 2.53193757 |
| 36 | Aortic dissection (HP:0002647) | 2.50731556 |
| 37 | Limb-girdle muscle atrophy (HP:0003797) | 2.50339117 |
| 38 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.49874875 |
| 39 | Postural tremor (HP:0002174) | 2.43459691 |
| 40 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.40314720 |
| 41 | Limb-girdle muscle weakness (HP:0003325) | 2.39685764 |
| 42 | Resting tremor (HP:0002322) | 2.33334085 |
| 43 | Bladder diverticulum (HP:0000015) | 2.33218344 |
| 44 | Progressive cerebellar ataxia (HP:0002073) | 2.32188355 |
| 45 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.31835026 |
| 46 | Neoplasm of the heart (HP:0100544) | 2.31572420 |
| 47 | Apathy (HP:0000741) | 2.30949914 |
| 48 | Wormian bones (HP:0002645) | 2.30748809 |
| 49 | Back pain (HP:0003418) | 2.30539483 |
| 50 | Torticollis (HP:0000473) | 2.29942369 |
| 51 | Spastic gait (HP:0002064) | 2.25965017 |
| 52 | Failure to thrive in infancy (HP:0001531) | 2.24143091 |
| 53 | Hypercortisolism (HP:0001578) | 2.24072558 |
| 54 | Achilles tendon contracture (HP:0001771) | 2.24007720 |
| 55 | Febrile seizures (HP:0002373) | 2.23441506 |
| 56 | Neurofibrillary tangles (HP:0002185) | 2.22766249 |
| 57 | Rapidly progressive (HP:0003678) | 2.20592462 |
| 58 | Distal lower limb amyotrophy (HP:0008944) | 2.19955789 |
| 59 | Hand muscle atrophy (HP:0009130) | 2.19930896 |
| 60 | Anxiety (HP:0000739) | 2.19544707 |
| 61 | Hammertoe (HP:0001765) | 2.19202433 |
| 62 | EEG with generalized epileptiform discharges (HP:0011198) | 2.18625313 |
| 63 | Upper limb amyotrophy (HP:0009129) | 2.18024388 |
| 64 | Distal upper limb amyotrophy (HP:0007149) | 2.18024388 |
| 65 | Distal lower limb muscle weakness (HP:0009053) | 2.17984759 |
| 66 | Difficulty climbing stairs (HP:0003551) | 2.17765634 |
| 67 | Hypsarrhythmia (HP:0002521) | 2.17645461 |
| 68 | Epileptiform EEG discharges (HP:0011182) | 2.15550661 |
| 69 | Neuroendocrine neoplasm (HP:0100634) | 2.15504413 |
| 70 | Agitation (HP:0000713) | 2.13772685 |
| 71 | Urinary urgency (HP:0000012) | 2.13188472 |
| 72 | Growth hormone excess (HP:0000845) | 2.12677588 |
| 73 | Generalized hypotonia (HP:0001290) | 2.12611127 |
| 74 | Shallow orbits (HP:0000586) | 2.12338227 |
| 75 | Dysdiadochokinesis (HP:0002075) | 2.12085487 |
| 76 | Slender build (HP:0001533) | 2.10891658 |
| 77 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.10030079 |
| 78 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.10030079 |
| 79 | Fragile skin (HP:0001030) | 2.09083942 |
| 80 | Hepatoblastoma (HP:0002884) | 2.08823261 |
| 81 | Neuronal loss in central nervous system (HP:0002529) | 2.07705721 |
| 82 | Focal dystonia (HP:0004373) | 2.06801657 |
| 83 | Exercise-induced muscle cramps (HP:0003710) | 2.05156097 |
| 84 | Soft skin (HP:0000977) | 2.04121098 |
| 85 | Hypoventilation (HP:0002791) | 2.04108432 |
| 86 | Abnormality of the Achilles tendon (HP:0005109) | 2.03705254 |
| 87 | Diminished motivation (HP:0000745) | 2.02660404 |
| 88 | Increased connective tissue (HP:0009025) | 2.02610005 |
| 89 | Posterior subcapsular cataract (HP:0007787) | 2.02604420 |
| 90 | Mutism (HP:0002300) | 2.02277069 |
| 91 | Hemiparesis (HP:0001269) | 2.01845667 |
| 92 | Craniofacial dystonia (HP:0012179) | 2.00995790 |
| 93 | Cholecystitis (HP:0001082) | 2.00205887 |
| 94 | Abnormal gallbladder physiology (HP:0012438) | 2.00205887 |
| 95 | Axonal loss (HP:0003447) | 1.98789079 |
| 96 | Hyperextensible skin (HP:0000974) | 1.98716574 |
| 97 | Hyperventilation (HP:0002883) | 1.98388432 |
| 98 | Megalencephaly (HP:0001355) | 1.98106167 |
| 99 | Papilledema (HP:0001085) | 1.98071601 |
| 100 | Ankyloglossia (HP:0010296) | 1.97899894 |
| 101 | Short nail (HP:0001799) | 1.97505735 |
| 102 | Generalized myoclonic seizures (HP:0002123) | 1.96336008 |
| 103 | Central scotoma (HP:0000603) | 1.95588596 |
| 104 | Lower limb amyotrophy (HP:0007210) | 1.95566964 |
| 105 | Cervical subluxation (HP:0003308) | 1.94674321 |
| 106 | Myopathic facies (HP:0002058) | 1.94591015 |
| 107 | Scanning speech (HP:0002168) | 1.94435848 |
| 108 | Abnormal eating behavior (HP:0100738) | 1.92935191 |
| 109 | Abnormality of pain sensation (HP:0010832) | 1.92388219 |
| 110 | Impaired pain sensation (HP:0007328) | 1.92388219 |
| 111 | Aortic aneurysm (HP:0004942) | 1.91588135 |
| 112 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.90935985 |
| 113 | Limb dystonia (HP:0002451) | 1.90490419 |
| 114 | Mitral regurgitation (HP:0001653) | 1.90449379 |
| 115 | Scapular winging (HP:0003691) | 1.89847228 |
| 116 | Postural instability (HP:0002172) | 1.89490987 |
| 117 | Round ear (HP:0100830) | 1.89411537 |
| 118 | Blue sclerae (HP:0000592) | 1.88016579 |
| 119 | Status epilepticus (HP:0002133) | 1.87972034 |
| 120 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.87571648 |
| 121 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.87230955 |
| 122 | Peripheral hypomyelination (HP:0007182) | 1.87038618 |
| 123 | Asymmetric septal hypertrophy (HP:0001670) | 1.85775922 |
| 124 | Nemaline bodies (HP:0003798) | 1.85333128 |
| 125 | Abnormal social behavior (HP:0012433) | 1.84505173 |
| 126 | Impaired social interactions (HP:0000735) | 1.84505173 |
| 127 | Peritonitis (HP:0002586) | 1.84447272 |
| 128 | Drooling (HP:0002307) | 1.83479794 |
| 129 | Excessive salivation (HP:0003781) | 1.83479794 |
| 130 | Muscle fiber inclusion bodies (HP:0100299) | 1.82787278 |
| 131 | Dysmetria (HP:0001310) | 1.82780691 |
| 132 | Ventricular fibrillation (HP:0001663) | 1.82366491 |
| 133 | Truncal ataxia (HP:0002078) | 1.82066730 |
| 134 | Genu recurvatum (HP:0002816) | 1.81974673 |
| 135 | Long toe (HP:0010511) | 1.81590987 |
| 136 | Buphthalmos (HP:0000557) | 1.80713489 |
| 137 | Poor eye contact (HP:0000817) | 1.80072572 |
| 138 | Nuclear cataract (HP:0100018) | 1.79427539 |
| 139 | Foot dorsiflexor weakness (HP:0009027) | 1.79337239 |
| 140 | Myotonia (HP:0002486) | 1.79046725 |
| 141 | Delusions (HP:0000746) | 1.78706950 |
| 142 | Cerebral aneurysm (HP:0004944) | 1.78114728 |
| 143 | Intellectual disability, profound (HP:0002187) | 1.77326956 |
| 144 | Bradykinesia (HP:0002067) | 1.76260501 |
| 145 | Mitral stenosis (HP:0001718) | 1.76256387 |
| 146 | Clonus (HP:0002169) | 1.76076394 |
| 147 | Elbow flexion contracture (HP:0002987) | 1.75859845 |
| 148 | Muscle stiffness (HP:0003552) | 1.75754351 |
| 149 | Lower limb muscle weakness (HP:0007340) | 1.75341170 |
| 150 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.74084298 |
| 151 | Obstructive sleep apnea (HP:0002870) | 1.73175011 |
| 152 | Pelvic girdle muscle weakness (HP:0003749) | 1.72804698 |
| 153 | Scotoma (HP:0000575) | 1.72140516 |
| 154 | Abnormality of the calf musculature (HP:0001430) | 1.71949487 |
| 155 | Abnormal neuron morphology (HP:0012757) | 1.71038828 |
| 156 | Abnormality of the motor neurons (HP:0002450) | 1.71038828 |
| 157 | Hyperparathyroidism (HP:0000843) | 1.70326422 |
| 158 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.69979615 |
| 159 | Long palpebral fissure (HP:0000637) | 1.69974523 |
| 160 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.69117341 |
| 161 | Myoglobinuria (HP:0002913) | 1.68876992 |
| 162 | Cortical dysplasia (HP:0002539) | 1.68751034 |
| 163 | Abnormality of the foot musculature (HP:0001436) | 1.68651314 |
| 164 | Muscle fiber splitting (HP:0003555) | 1.68609511 |
| 165 | Dilatation of the ascending aorta (HP:0005111) | 1.68452222 |
| 166 | Intention tremor (HP:0002080) | 1.68203209 |
| 167 | Insomnia (HP:0100785) | 1.66250948 |
| 168 | Hydroureter (HP:0000072) | 1.65976617 |
| 169 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.65671449 |
| 170 | Shoulder girdle muscle weakness (HP:0003547) | 1.64446141 |
| 171 | Bilateral microphthalmos (HP:0007633) | 1.62569795 |
| 172 | Congenital glaucoma (HP:0001087) | 1.60980055 |
| 173 | Horizontal nystagmus (HP:0000666) | 1.60764473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.69265704 |
| 2 | TESK1 | 4.22688996 |
| 3 | NTRK3 | 3.27625237 |
| 4 | KSR2 | 3.10144310 |
| 5 | MAP3K4 | 2.82036589 |
| 6 | NTRK1 | 2.64068592 |
| 7 | LATS2 | 2.63197849 |
| 8 | MARK1 | 2.62406630 |
| 9 | ARAF | 2.57225164 |
| 10 | GRK5 | 2.54311721 |
| 11 | MINK1 | 2.26697653 |
| 12 | PAK6 | 2.23246119 |
| 13 | MAP2K4 | 2.09660032 |
| 14 | PRKD3 | 1.88302970 |
| 15 | PIM2 | 1.86156823 |
| 16 | MOS | 1.69678463 |
| 17 | SCYL2 | 1.67574589 |
| 18 | EPHA4 | 1.65824754 |
| 19 | MAP2K7 | 1.63629769 |
| 20 | NEK1 | 1.58676511 |
| 21 | PRPF4B | 1.58157229 |
| 22 | MAP3K2 | 1.57799149 |
| 23 | KSR1 | 1.57254665 |
| 24 | TYRO3 | 1.55976318 |
| 25 | ERN1 | 1.48404414 |
| 26 | TAOK1 | 1.47892137 |
| 27 | UHMK1 | 1.47584013 |
| 28 | TAOK2 | 1.39795141 |
| 29 | PLK2 | 1.36597654 |
| 30 | DAPK2 | 1.34235326 |
| 31 | MAP3K11 | 1.33921689 |
| 32 | EPHB1 | 1.30428157 |
| 33 | MYLK | 1.28199416 |
| 34 | TTN | 1.27738132 |
| 35 | EPHB2 | 1.22626254 |
| 36 | MAP3K12 | 1.22543087 |
| 37 | PAK3 | 1.21958210 |
| 38 | NTRK2 | 1.18757050 |
| 39 | ALK | 1.17779827 |
| 40 | RET | 1.15613404 |
| 41 | CDK14 | 1.15606408 |
| 42 | CAMKK1 | 1.15285365 |
| 43 | CDK5 | 1.13591664 |
| 44 | EPHA2 | 1.12506724 |
| 45 | PRKD2 | 1.10295044 |
| 46 | BCR | 1.10095360 |
| 47 | CDK19 | 1.09184308 |
| 48 | CDK12 | 1.08449456 |
| 49 | PHKG2 | 1.05402038 |
| 50 | PHKG1 | 1.05402038 |
| 51 | CDK15 | 1.01296988 |
| 52 | CDK18 | 1.01064532 |
| 53 | LIMK1 | 1.00788490 |
| 54 | BCKDK | 1.00152201 |
| 55 | PAK4 | 0.99266042 |
| 56 | EPHA3 | 0.98015782 |
| 57 | MAP3K1 | 0.97973568 |
| 58 | BRAF | 0.97095905 |
| 59 | GRK6 | 0.96687677 |
| 60 | PRKCH | 0.92888161 |
| 61 | MAP2K1 | 0.92858249 |
| 62 | DYRK1B | 0.90842315 |
| 63 | MAP4K2 | 0.88496554 |
| 64 | DDR2 | 0.88319734 |
| 65 | CDK11A | 0.87699800 |
| 66 | STK38 | 0.87531478 |
| 67 | TRIB3 | 0.87275722 |
| 68 | PDGFRA | 0.86914343 |
| 69 | PRKCG | 0.85444292 |
| 70 | RAF1 | 0.85039294 |
| 71 | HIPK2 | 0.83649153 |
| 72 | MAPK13 | 0.82423740 |
| 73 | CSNK1G2 | 0.81041906 |
| 74 | MAP3K6 | 0.79688179 |
| 75 | DAPK1 | 0.78118471 |
| 76 | ABL2 | 0.77129195 |
| 77 | MARK2 | 0.77063544 |
| 78 | PNCK | 0.73355213 |
| 79 | MAP3K5 | 0.71771367 |
| 80 | DAPK3 | 0.68937757 |
| 81 | PTK2 | 0.68865367 |
| 82 | FER | 0.67067417 |
| 83 | CAMK2A | 0.66538946 |
| 84 | MAP3K13 | 0.65881268 |
| 85 | MAP3K3 | 0.65370547 |
| 86 | IRAK3 | 0.65078369 |
| 87 | SGK494 | 0.65036024 |
| 88 | SGK223 | 0.65036024 |
| 89 | ICK | 0.64424359 |
| 90 | PAK2 | 0.64389293 |
| 91 | DYRK1A | 0.62932272 |
| 92 | CSNK1G1 | 0.62284482 |
| 93 | WNK1 | 0.61847903 |
| 94 | DYRK2 | 0.60977716 |
| 95 | ADRBK1 | 0.58923954 |
| 96 | STK11 | 0.53876332 |
| 97 | SIK1 | 0.53250910 |
| 98 | NEK9 | 0.52752650 |
| 99 | CAMKK2 | 0.51289010 |
| 100 | PRKD1 | 0.49085639 |
| 101 | CSNK1G3 | 0.48927440 |
| 102 | PKN2 | 0.47962348 |
| 103 | MAPKAPK3 | 0.47685088 |
| 104 | ERBB4 | 0.46842554 |
| 105 | SIK2 | 0.45977494 |
| 106 | MET | 0.44831510 |
| 107 | TGFBR2 | 0.42600898 |
| 108 | CAMK4 | 0.41889771 |
| 109 | MAPK12 | 0.41257147 |
| 110 | ROCK1 | 0.40468134 |
| 111 | CAMK2B | 0.40339019 |
| 112 | MAPK10 | 0.40048995 |
| 113 | AKT2 | 0.39682665 |
| 114 | RPS6KA2 | 0.39662248 |
| 115 | CDC42BPA | 0.38753795 |
| 116 | PAK1 | 0.38463786 |
| 117 | LMTK2 | 0.38429879 |
| 118 | TESK2 | 0.37758882 |
| 119 | MATK | 0.37758072 |
| 120 | PDPK1 | 0.37755060 |
| 121 | ROCK2 | 0.37720750 |
| 122 | CASK | 0.37351699 |
| 123 | RPS6KA3 | 0.37242562 |
| 124 | RIPK1 | 0.37072471 |
| 125 | CSNK1E | 0.36276207 |
| 126 | DYRK3 | 0.35764631 |
| 127 | PRKCI | 0.35635757 |
| 128 | PRKCZ | 0.35395331 |
| 129 | ERBB3 | 0.34295973 |
| 130 | CSNK1A1L | 0.33699050 |
| 131 | CAMK2G | 0.31197852 |
| 132 | PTK2B | 0.29523886 |
| 133 | MAP3K7 | 0.29109203 |
| 134 | WNK4 | 0.27089142 |
| 135 | CAMK2D | 0.27034227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.53737367 |
| 2 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.71809917 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.38597199 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.32315631 |
| 5 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.27510170 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.25899508 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.11207944 |
| 8 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.08444798 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.01174332 |
| 10 | Insulin secretion_Homo sapiens_hsa04911 | 2.00493133 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 1.99467299 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.94301121 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.91928601 |
| 14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.71316348 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.64448052 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.62973709 |
| 17 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.61918067 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.61334645 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.59936848 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.59889621 |
| 21 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.57635086 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.55559328 |
| 23 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53704762 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.50850433 |
| 25 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.48489156 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.48467841 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.47365092 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.46254552 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.46191813 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.46099372 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.45900448 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.45529505 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.45403620 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.45102886 |
| 35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.39362590 |
| 36 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.36896485 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.32345392 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.30967540 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.27345753 |
| 40 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.25838002 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.19668162 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.19103487 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 1.18866394 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.18069257 |
| 45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.16879323 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13740455 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.13089213 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10554080 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09406410 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07157524 |
| 51 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.04359099 |
| 52 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.03910147 |
| 53 | Axon guidance_Homo sapiens_hsa04360 | 1.01785250 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.01124171 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00804510 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.99800827 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 0.99533086 |
| 58 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 0.98215454 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96515543 |
| 60 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.95909632 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.95479604 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.93408690 |
| 63 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.93029272 |
| 64 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92245621 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91665640 |
| 66 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.90899232 |
| 67 | Melanogenesis_Homo sapiens_hsa04916 | 0.90356231 |
| 68 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.87992039 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87187754 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.86874361 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85555440 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85273588 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.84732262 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83922634 |
| 75 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83003728 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.81607074 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80540286 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80455015 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80060999 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.79823590 |
| 81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.79730625 |
| 82 | Phototransduction_Homo sapiens_hsa04744 | 0.76581206 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.76195595 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.73669599 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73496855 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72243391 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72198493 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72148731 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.71993680 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71337289 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70624651 |
| 92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.69772585 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.67631791 |
| 94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.67088200 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66712807 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66508853 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.65665328 |
| 98 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.65052412 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.64951137 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64653155 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64205535 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63169452 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63038901 |
| 104 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.63006454 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62781064 |
| 106 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62764079 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61961612 |
| 108 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61211814 |
| 109 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60638378 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60200901 |
| 111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60042357 |
| 112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59730754 |
| 113 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57332944 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56475793 |
| 115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55401101 |
| 116 | Bile secretion_Homo sapiens_hsa04976 | 0.55354882 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54561327 |
| 118 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53880342 |
| 119 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.53295325 |
| 120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53142107 |
| 121 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52013387 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51176715 |
| 123 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50782411 |
| 124 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50324292 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50037426 |
| 126 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49601499 |
| 127 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.48901113 |
| 128 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47929337 |
| 129 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47551812 |
| 130 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47541316 |
| 131 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47282349 |
| 132 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.46977329 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46586235 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46381283 |
| 135 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45316527 |
| 136 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45036907 |
| 137 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44585470 |
| 138 | Tight junction_Homo sapiens_hsa04530 | 0.42028848 |
| 139 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39756905 |
| 140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39656284 |

